January 2023 in “Dermatologìâ ta venerologìâ” This study found that using a combination of "Volvit tablets" (biotin 5 mg) and "Volvit intensive care shampoo" with biotin in patients with diffuse telogen alopecia stopped hair loss and restored hair follicles to normal function, suggesting effectiveness and safety for wide clinical use.
February 2020 in “Scholars academic journal of pharmacy” This case report describes a 78-year-old patient whose orlistat treatment for obesity likely led to hepatotoxicity, which improved after the medication was discontinued.
This chapter discusses the mechanisms, presentation, course, differential diagnosis, and treatment of drug-induced skin reactions and reports no new clinical results.
March 2026 in “International Journal of Dermatology Venereology and Leprosy Sciences” This study describes vitiligo as an autoimmune disease marked by depigmented skin and mucosal patches, and reviews its complex pathogenesis and diagnostic features. Treatment aims for disease control and repigmentation through various topical and systemic therapies, phototherapy, and surgical options, emphasizing personalized, multimodal approaches.
December 2023 in “PubMed” This study highlights that homemade topical herbal preparations, although popular for their perceived safety, may lead to allergic reactions, notably with Mediterranean herbs, and advises cautious use, particularly for allergy-prone individuals.
15 citations
,
January 2014 in “Dermatology” This study found a relatively low prevalence of cutaneous reactions in chronic hepatitis C patients treated with peginterferon alfa and ribavirin, with reactions correlated to age and treatment duration.
32 citations
,
October 2009 in “Dermatology” This article describes acute and chronic telogen effluvium, highlighting the importance of differentiating them from androgenetic alopecia for accurate diagnosis and treatment strategies but includes no new clinical research findings.
2 citations
,
October 2015 in “Primary Care: Clinics in Office Practice” This article discusses the evaluation and treatment options for alopecia but reports no new clinical results; it highlights the importance of early diagnosis and appropriate treatment.
64 citations
,
February 1995 in “Journal of The American Academy of Dermatology” This report describes a case where hidradenitis suppurativa developed in a patient receiving lithium, adding to the recognized cutaneous side effects like psoriasis, acneiform lesions, and alopecia.
7 citations
,
January 2021 in “Frontiers in genetics” This study suggests an association between DNA methylation changes in hair follicles and inherited color dilution in Rex rabbits, contributing to a deeper understanding of epigenetic influences on rabbit pigmentation.
January 2022 in “Skin appendage disorders” In this study, the researchers found that trichoscopy can effectively visualize scalp micropigmentation, identified by homogenous, grey to black circular dots similar to closely cut hair, potentially reducing the need for invasive procedures.
13 citations
,
November 2022 in “Chemical Science” This review discusses the use of inorganic-based biomaterials for hemostasis and wound healing, including various preparation methods and mechanisms, but reports no new clinical results.
May 2025 in “Journal of Cosmetic Dermatology” This research emphasizes the importance of integrating pre-treatment psychological assessments for individuals considering finasteride, highlighting that these assessments could help identify those prone to nocebo responses, potentially reducing adverse symptom development more related to cognitive vulnerabilities than to the drug itself.
1 citations
,
February 2024 in “Gynecological Endocrinology” This study found that cyclic MPA is as effective as OCPs in resuming ovulation among women with PCOS, offering a viable alternative for those who cannot or choose not to use OCPs.
1 citations
,
April 2022 in “JAAD case reports” In this case report, researchers observed that a 47-year-old woman developed pityriasis amiantacea after using topical minoxidil, suggesting a potential new etiology for this scalp condition.
September 2025 in “Case Reports in Ophthalmology” This case report suggests that even short-term use of topical minoxidil, as brief as one week, can induce central serous chorioretinopathy, which may resolve with medication discontinuation and observation.
May 2025 in “Dermatology Online Journal” This report describes a rare case of eyelash overgrowth and eyelid irritation in a woman treated with erlotinib for lung adenocarcinoma, highlighting a potential side effect of the drug.
April 2025 in “International Journal For Multidisciplinary Research” This study explores hypertrichosis, a condition of excessive hair growth, highlighting its classification, diagnostic methods, and potential treatments. The authors emphasize the importance of individualized approaches and further genetic research to enhance treatment options for this primarily cosmetic issue that can signal systemic diseases.
January 2022 in “Clinical Cases in Dermatology” This review discusses drug-induced alopecia, highlighting challenges in diagnosis and available therapies, and reports no new clinical results; the authors emphasize the need for further research into effective treatments.
March 2020 in “bioRxiv (Cold Spring Harbor Laboratory)” In this study, researchers found no monthly variations in perceived health of Hartley Albino guinea pigs or correlations with experimental completion rates, suggesting mild hair or weight loss may not impact their use in cardiac research.
53 citations
,
July 2018 in “Drug design, development and therapy” This review summarizes existing evidence on the efficacy and safety of JAK inhibitors for treating alopecia areata and emphasizes the need for improved topical formulations.
26 citations
,
June 2020 in “The Journal of Allergy and Clinical Immunology In Practice” This case study highlights that even short-term use of hydroxychloroquine for COVID-19 can potentially lead to acute generalized exanthematous pustulosis as an adverse effect.
24 citations
,
January 2018 in “International Journal of Trichology” This study found that oral tofacitinib was effective in promoting hair regrowth in patients with alopecia universalis, although further controlled studies are recommended to confirm its safety and efficacy.
20 citations
,
September 1995 in “PubMed” This review discusses the wide range of drugs potentially causing reversible or irreversible hair loss and emphasizes the difficulty of diagnosing drug-induced alopecia without withdrawal of the suspected medication; it reports no new clinical findings.
8 citations
,
December 2024 in “Frontiers in Medicine” In this study, different treatments on ex vivo skin models effectively simulated varying levels of skin damage, demonstrating the value of these models in testing skin repair products and studying how a compromised skin barrier affects viral penetration.
5 citations
,
December 2012 in “PubMed” This study describes the first reported case of a successful full-term pregnancy and live birth after long-term use of finasteride, suggesting it may not prevent normal conception despite initial severe oligospermia after discontinuation.
5 citations
,
May 2023 in “Clinical Rheumatology” This case report highlights a 33-year-old female with systemic lupus erythematosus and refractory alopecia who experienced significant hair regrowth after treatment with tofacitinib, maintained even after glucocorticoid tapering over two years.
4 citations
,
January 2025 in “Clinical Nutrition” This study found that irregular breakfasts and late-night snacking were associated with a higher risk of metabolic dysfunction-associated steatotic liver disease and increased alcohol intake-related liver disease.
3 citations
,
September 2023 in “International journal of impotence research” The authors concluded that finasteride and dutasteride might have serious side effects, including persistent sexual dysfunction for some, necessitating further research and vigilant risk-benefit analysis.
1 citations
,
May 2024 in “The Journal of Sexual Medicine” This case report suggests that clomiphene citrate can effectively restore fertility in some men with a long history of anabolic steroid abuse, though individual responses to treatment vary.